Keywords: فاز اول; AEs; adverse events; ELISA; enzyme-linked immunosorbent assay; SD; standard deviation; TEAEs; treatment emergent adverse events; TMB; 3,3â²,5,5â²-tetramethylbenzidine; EPT; end-point titre; MSD; mesoscale discovery; ECL; electrochemiluminescence; Ply; p
مقالات ISI فاز اول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فاز اول; Personalized medicine; Phase I; Clinical trials; Targeted therapy; Genomic profiling;
Keywords: فاز اول; GLP-1 receptor agonist; pharmacodynamics; phase I; AUC24; Area under the plasma concentration time curve from 0 to 24 hours afterdose in steady state; BMI; Body mass index; CL/F; Apparent clearance; Ctrough; Trough concentration; FPG; Fasting plasma gluco
Keywords: فاز اول; Alzheimer's disease; Phase I; Phase II; Phase III; Biomarkers; Preclinical AD; Prodromal AD; AD dementia;
Keywords: فاز اول; Pharmacodynamics; Biomarkers; Biopsy surrogate tissues; Phase I; Drug evaluation;
Keywords: فاز اول; Phase I; Palbociclib; Cetuximab; Head and neck cancer; Squamous cell carcinoma
Keywords: فاز اول; Alzheimer's disease; Drug development; Phase I; Phase II; Phase III; Biomarkers; Amyloid; Tau; Cognitive enhancement;
Keywords: فاز اول; Pinocembrin; Pharmacokinetics; Phase I; Safety; Tolerability;
Keywords: فاز اول; Phase I; Oncology clinical trials; Elderly
Keywords: فاز اول; Genomics; Phase I; Clinical trials;
Keywords: فاز اول; Influenza; Cell culture; Live attenuated; Vaccine; Healthy volunteers; Clinical trial; Phase I;
Keywords: فاز اول; Metastatic; Phase I; Renal; Survival; Trial
Keywords: فاز اول; Bioassay; Dose-finding; Experimental design; Fisher's information; Observed information; Optimal design; Phase I; Response-adaptive design
Keywords: فاز اول; Acute myeloid leukemia; Clinical trial; Cytarabine; Lenalidomide; Phase I; Relapse/refractory AML
Genioglossus muscle advancement and simultaneous sliding genioplasty in the management of sleep apnoea
Keywords: فاز اول; genioplasty; genioglossus muscle advancement; obstructive sleep apnoea; phase I;
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies
Keywords: فاز اول; Ovarian cancer; Phase I; Veliparib; PARP inhibitor; BRCA1/2 mutations;
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid
Keywords: فاز اول; Phase I; Radiosensitization; ATR inhibition; DNA damage response; Clinical trial;
The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers
Keywords: فاز اول; Phase I; Healthy volunteers; Pharmacokinetics; Phosphodiesterase inhibitors; Safety;
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer
Keywords: فاز اول; Breast cancer; Buparlisib; Capecitabine; PI3K; Phase I;
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
Keywords: فاز اول; Combination Therapy; Overall response rate; Phase I; Phase II; Relapsed and refractory lymphoma;
Enhancement of TCE removal by a static magnetic field in a fungal biotrickling filter
Keywords: فاز اول; BTF; biotrickling filter; MF; magnetic field; MFI; magnetic field intensities; TCE; trichloroethylene; EC; elimination capacity; RE; removal efficiency; ILR; inlet loading rate; Phase I; Start-up; Phase II; MFI 0â¯mT; Phase III; MFI 20.0â¯mT; Phase IV;
Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial
Keywords: فاز اول; Hepatocellular carcinoma; Idarubicin; Chemolipiodolisation; Phase I;
Characterization of ethoxyresorufin O-deethylase activity (EROD) in oyster Crassostrea brasiliana
Keywords: فاز اول; 7-ER; 7-ethoxyresorufin; AHRs; aryl hydrocarbon receptors; ANF; α-naphthoflavone; CYP; cytochrome p450; DMSO; dimethyl sulfoxide; DTT; dl-dithiothreitol; ELP; ellipticine; EROD; 7-ethoxyresorufin O-deethylase activity; FRF; furafylline; NADH; β-nicotina
Original ResearchClinical trial simulations in paediatric oncology: AÂ feasibility study from the Innovative Therapies for Children with Cancer Consortium
Keywords: فاز اول; Pediatrics; Clinical trial; Phase I; CML; Pharmacokinetics; Simulations;
Candidate cytochrome P450 genes for ethoxyresorufin O-deethylase activity in oyster Crassostrea gigas
Keywords: فاز اول; ANF; α-naphthoflavone; CTZ; clotrimazole; CYP1; cytochrome P450 1; DMSO; dimethyl sulfoxide; DTT; DL-dithiothreitol; ELP; ellipticine; EROD; ethoxyresorufin O-deethylase activity; FRF; furafylline; NADH; β-nicotinamide adenine dinucleotide reduced; NADP
French Jardé's law and European regulation on drug trials: Harmonization and implementation of new rules
Keywords: فاز اول; Regulation; Clinical research; Jardé's law; European regulation; Adverse effects; Ethics committee; Phase I; Training;
Original ResearchA dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir
Keywords: فاز اول; Docetaxel; Ritonavir; Oral docetaxel; ModraDoc001; ModraDoc006; Phase I;
Original ResearchPhase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours
Keywords: فاز اول; Phase I; EGFR; mTOR; PIK3CA; Precision medicine;
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification
Keywords: فاز اول; MET-inhibitor; Advanced solid tumours; NSCLC; MET-amplified; Phase I; Dose escalation;
Original ResearchSafety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
Keywords: فاز اول; LY2780301; Gemcitabine; PI3K/AKT/mTOR pathway; Dual p70S6K/AKT inhibition; PTEN; Molecular alterations; Phase I; Molecular screening; Drug development;
Clinical TrialPhase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
Keywords: فاز اول; Everolimus; Axitinib; Phase I; Solid tumours; Renal cell carcinoma;
Population pharmacokinetics of NNZ-2566 in healthy subjects
Keywords: فاز اول; NNZ-2566; Population pharmacokinetics; First-time-in-humans; Rare diseases; Phase I; Modelling and simulation; Trofinetide;
Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience
Keywords: فاز اول; Phase I; Targeted therapy; Toxicity; Dose; Efficacy;
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial
Keywords: فاز اول; First line treatment for breast cancer; HER2-negative breast cancer; Metastatic breast cancer; Phase I; Phase II;
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Keywords: فاز اول; Human double minute 2 inhibitor; MK-8242; Acute myelogenous leukemia; p53; Phase I;
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas
Keywords: فاز اول; Phase I; MUC1; Glyco-optimised monoclonal antibody; Glycopeptide epitope; Solid tumours;
Original ResearchA phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
Keywords: فاز اول; MEK inhibitor; Phase I; Pharmacodynamics; Pharmacokinetics; Optimal biological dose;
Pharmacokinetics of Weekly Paclitaxel and Feasibility of Dexamethasone Taper in Japanese Patients with Advanced Non-small Cell Lung Cancer
Keywords: فاز اول; dexamethasone; paclitaxel; pharmacokinetics; phase I; safety;
Innovations for phase I dose-finding designs in pediatric oncology clinical trials
Keywords: فاز اول; Dose-finding clinical trials; Phase I; Adaptive designs; Oncology; Pediatrics; Review;
dfcomb: An R-package for phase I/II trials of drug combinations
Keywords: فاز اول; Dose-finding; Phase I; Combination; Adaptive design; R package;
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)
Keywords: فاز اول; Small cell; Veliparib; PARP; Phase I;
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer
Keywords: فاز اول; Anal cancer; 5-Fluorouracil; Mitomycin C; Cetuximab; Phase I; Radiotherapy
Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel: A Phase 1 Study in Japanese Patients with Previously Treated Non-Small-Cell Lung Cancer
Keywords: فاز اول; Clinical trials; Phase I; Docetaxel; Japanese; Nintedanib; Non-small-cell lung cancer; Pharmacokinetics;
Bayesian dose escalation in oncology with sharing of information between patient populations
Keywords: فاز اول; Maximum tolerated dose; Pediatrics; Continual reassessment method; Phase I; Bayesian; Adaptive clinical trial;
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours
Keywords: فاز اول; Ridaforolimus; mTOR inhibitor; MK-0752; Notch inhibitor; Head and neck cancer; Phase I;
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?
Keywords: فاز اول; Renal dysfunction; Phase I;
Referrals to phase I clinical trials in a gynecologic oncology unit
Keywords: فاز اول; Phase I; Targeted therapy; Platinum resistant
An evaluation of elderly patients (â¥Â 70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011
Keywords: فاز اول; Phase I; Elderly; Geriatric assessment;
A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin-Vinorelbine-Cetuximab in Patients With Stage III Non-Small-Cell Lung Cancer
Keywords: فاز اول; NSCLC; Concurrent chemoradiotherapy; Cetuximab; Phase I;
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours
Keywords: فاز اول; Heat shock protein 90 inhibitor; Phase I; SNX-5422; SNX-2112; Solid tumours;